OBJECTIVE: Secondary severe fetal growth restriction (FGR, fetal growth discordance of ! 25% in monochorionic twins), is associated with increased perinatal mortality and morbidity in twintwin transfusion syndrome (TTTS) . In this study we identified risk factors for worsening or improved growth discordance in patients undergoing fetoscopic laser surgery (FLS) for TTTS. STUDY DESIGN: Prospective cohort of monochorionic diamniotic twin patients undergoing FLS for TTTS (N¼ 311) at a single fetal center from 2012-2017. Exclusion criteria were triplet gestation and intrauterine demise. Overall growth discordance at pre-op and at delivery was compared. Three groups were identified: Group 1-worsening discordance (+/-pre-op FGR and + FGR at delivery), Group 2-improved discordance (+ pre-op FGR and -FGR at delivery) , and Group 3-stable without FGR. Comparative analysis was performed between the two most divergent outcomes: Group 1 vs. Group 2. RESULTS: 242 patients met inclusion criteria: Median fetal growth discordance in the entire cohort before FLS was 22% (IQR 13% -31%) vs. 11% at birth (IQR 4% -23%); p<0.001. Group 1 had 57 patients, Group 2 had 65 patients and Group 3 had 120 patients. The significant and most relevant variables between groups are presented in Table 1 . Patients in Group 1 were more likely to have an earlier delivery and fewer neonatal survivors. Risk factors for Group 1 in comparison to Group 2 are presented in Figure 1 by stepwise logistic regression. These include, recipient MVP, donor fetus velamentous cord insertion and presence of A-A anastomosis. CONCLUSION: On average, patients who undergo FLS for TTTS show improvement in fetal weight discordance at birth. However, a subgroup of patients has worsening discordance and poor neonatal outcomes. Placental share and vascular anatomy appear to drive post-procedure fetal growth patterns. These risk factors should be considered in pre-operative counseling and planning for FLS and long term outcomes for these neonates should be evaluated.
Poster Session I OBJECTIVE: Neonatal acidemia is associated with neonatal morbidity. Umbilical artery pH of 7.0 or 7.1 is often used as a threshold for assessing risk of neonatal morbidity and mortality. However, the relevance of mild acidemia above this threshold has not been adequately assessed. This study was designed to determine the association of incremental increases in pH and neonatal morbidity among neonates with mild academia, defined as pH between 7.11 and 7.19. STUDY DESIGN: This is a secondary analysis of a prospective cohort study of 8580 women who were admitted for labor at ! 37 weeks gestation within a single institution from 2010 to 2015. Umbilical cord blood gas assessment was performed during the study time. A composite neonatal morbidity index was created including death, respiratory distress, mechanical ventilation, meconium aspiration syndrome, suspected sepsis, hypoxic-ischemic encephalopathy, therapeutic hypothermia and seizures. Neonates with mild acidosis were divided into those with umbilical artery pH 7.11-7.14 and those with pH 7.15-7.19. Multivariable logistic regression was used to estimate the association between lower pH and neonatal morbidity while adjusting for confounders. RESULTS: Of the 8,580 participants, 669 (7.8%) had mild acidosis. Lower umbilical artery pH (7.11-7.14) was associated with increased risk of composite neonatal morbidity when compared to pH 7.15-7.19 (aOR 2.53 [1.59,4.03]; Table 1 ). Among individual components, lower pH was associated with increased neonatal respiratory distress and treatment for suspected sepsis although respiratory distress was no longer significant after adjustment. CONCLUSION: These data demonstrate that term neonates with mild acidemia at birth are at increased risk for immediate morbidity. Long term risks of mild acidemia at birth will need to be assessed, and the utility of potential interventions that benefit infants with moderate and severe acidemia should be explored among this population.
201 Premature placental aging in term small for gestational age and fetal growth restriction OBJECTIVE: From early to term pregnancy, the placenta normally presents progressive aging promoting cell death leading to decreased activity related to normal post-term changes. While previous studies in placentas from small fetuses suggested an accelerated placental aging process, it is unclear whether SGA -with apparent normal placental function by ultrasound-encompass premature placental aging or whether this phenomenon is restricted to FGR. The aim of this study was to perform a comprehensive assessment of the placental aging process through senescence and apoptotic markers in late-onset small fetuses classified as SGA or FGR. STUDY DESIGN: A nested case-control study in singleton pregnancies delivering at term including 21 normally grown fetuses and 36 small fetuses classified into SGA (if birthweight was between the 3rd and 9th centile and normal fetoplacental Doppler; n¼18) and FGR (if birthweight <3rd centile and/or abnormal cerebroplacental ratio or uterine artery Doppler; n¼18). Telomerase activity, telomere length and RNA expression of senescence (Sirtuin 1,3,6) and apoptotic markers (p53, p21, BAX, Caspase 3 and 9) were analyzed in placental samples collected at birth. RESULTS: Compared with normally grown fetuses, both SGA and FGR presented signs of accelerated placental aging including lower telomerase activity (controls meanAESD 12.8% AE 6.6 vs SGA 7.98% AE 4.2 vs FGR 7.79% AE 4.6, p¼0.008), shorter telomeres (controls 1.20 T/S AE 0.6 vs SGA 1.08 T/S AE 0.9 vs FGR 0.66 T/S AE 0. 
